BOQI International Medical Stock Rallies After Q2 Revenue Jump

BOQI International (NASDAQ: BIMI) reported its second-quarter 2020 financial results premarket today, initiating an over 70% move higher in the company’s share price. 

The company reported that its revenue for Q2 jumped by an impressive 1026% to $3.79 million compared to the same period last year. Its profit also rose to $4.64 million compared to a loss of $862 thousand last year. 

BOQI put its success during the quarter down to healthcare facilities re-opening and patient treatment resuming during the three months. 

WELCOME BONUS - Free Share Bundle When You Invest £50! Get up to £500 cashback for investing with IG.

Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply.

5.0

Open Account Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

“We acquired Guanzan Group this year, which allows us to better align with the current environment and positions us for future growth. As more healthcare facilities re-opened for business and resumed patient treatment in the second half of the year, we believe our products can meet the expected rising customer demand, meanwhile bring benefit to our shareholders,” stated Tiewei Song, BOQI’s CEO.

The company’s stock price is currently trading at $3.07, up 58% after Friday’s closing price of $1.94 per share.

PEOPLE WHO READ THIS ALSO VIEWED:

• Midatech Pharma stock jumps 35%, here’s why…
• Trade stocks with Plus500
• Learn stock trading strategies